切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2018, Vol. 12 ›› Issue (04) : 302 -305. doi: 10.3877/cma.j.issn.1674-3946.2018.04.011

所属专题: 文献

论著

纳米碳在甲状腺微小乳头状癌手术中对甲状旁腺及喉返神经的保护作用研究
孙荣能1, 赵迎春1,(), 曹晓丽1   
  1. 1. 241000 安徽,芜湖市第二人民医院甲乳外科
  • 收稿日期:2018-03-08 出版日期:2018-08-26
  • 通信作者: 赵迎春

Protective effect of nano-carbon on parathyroid gland and recurrent laryngeal nerve in papillary thyroid micro-carcinoma surgery

Rongneng Sun1, Yingchun Zhao1,(), Xiaoli Cao1   

  1. 1. Department of thyroid gland and Breast surgery, the second people’s Hospital of Wuhu City, the second people’s hospital of Wuhu city 241000
  • Received:2018-03-08 Published:2018-08-26
  • Corresponding author: Yingchun Zhao
  • About author:
    Corresponding author: Zhao Yingchun, Email:
  • Supported by:
    Project of Science and Technology plan 2015 of Wuhu City, Anhui 241000(NO.2015hm07)
引用本文:

孙荣能, 赵迎春, 曹晓丽. 纳米碳在甲状腺微小乳头状癌手术中对甲状旁腺及喉返神经的保护作用研究[J]. 中华普外科手术学杂志(电子版), 2018, 12(04): 302-305.

Rongneng Sun, Yingchun Zhao, Xiaoli Cao. Protective effect of nano-carbon on parathyroid gland and recurrent laryngeal nerve in papillary thyroid micro-carcinoma surgery[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(04): 302-305.

目的

探讨纳米碳在甲状腺微小乳头状癌手术中对甲状旁腺及喉返神经的保护作用。

方法

选取2015年6月至2017年5月行甲状腺微小乳头状癌手术的患者共67例作为本次研究对象,随机将67例患者分为纳米碳组(33例)和常规手术组(34例),常规手术组患者行常规手术治疗,纳米碳组患者术中加用纳米碳示踪剂。使用统计学软件SPSS19.0分析,术中术后指标,术前术后甲状旁激素、血钙水平变化以(±s)表示,采用独立t检验;术后并发症发生率,采用卡方检验,以P < 0.05为差异有统计学意义。

结果

两组患者术中出血量、手术时间、康复出院时间及甲状旁腺误切率(3.0%比32.4%)比较,纳米碳组均低于常规手术组(P<0.05),两组患者Ⅵ区淋巴结清扫数目、Ⅵ区淋巴结转移情况比较差异无统计学意义(P>0.05);两组患者术前甲状旁激素、血钙水平比较无差异(P>0.05),术后3 d内纳米碳组甲状旁激素、血钙水平明显高于常规手术组(P<0.05),术后7 d两组差异无统计学意义(P>0.05);纳米碳组患者术后声音嘶哑、自感发声无力、暂时性低血钙等并发症发生率明显低于常规手术组(P<0.05),术后3、6个月复查肿瘤病灶复发率纳米碳组低于常规手术组,但差异无统计学意义(P>0.05)。

结论

在甲状腺微小乳头状癌手术中使用纳米碳可清楚鉴别甲状旁腺和淋巴结,对保护甲状旁腺和周围正常组织有重要意义,值得推广。

Objective

To investigate the protective effect of nano carbon on parathyroid gland and recurrent laryngeal nerve in papillary thyroid micro-carcinoma surgery.

Methods

A total of 67 patients with papillary thyroid micro-carcinoma from June 2015 to May 2017 were enrolled into this study. 67 patients, who were randomly divided into nanometer carbon group (n=33) and routine operation group (n=34). The changes of parathyroid hormone, serum calcium level and postoperative complications were observed in both χ2 groups. Statistical analysis were performed by using SPSS 19.0 software. Perioperative measurement data, such as parathyroid hormones and serum calcium levels were expressed as (±s), and were examined by using t test.The postoperative complication rate was analyzed by Chi-square test. A P value <0.05 was considered as statistically significant difference.

Results

The intraoperative blood loss, operation time, recovery and discharge time and parathyroid miscut rate were significantly lower in nano-carbon group than those in routine operation group (P<0.05), and the Number of lymph node dissection in VI region of two groups was lower than that in conventional operation group. There was no significant difference in lymph node metastasis between two groups (P>0.05), there was no significant difference in terms of serum calcium and parathyroid hormone levels between two groups before operation (P>0.05), and within 3 days after operation, parathyroid hormone was found in the nano-carbon group. The level of serum calcium in routine operation group was significantly higher than that in routine operation group (P<0.05), and gradually recovered in routine operation group 7 days after operation, and there was no difference compared with nano-carbon group (P>0.05). The incidence of postoperative complications such as hoarseness, spontaneous voice weakness and transient hypocalcemia in the carbon group was significantly lower than those in the routine operation group (P<0.05). The recurrence rate of tumor focus in nano-carbon group was lower than that in conventional operation group 3 and 6 months after operation, with no significant difference (P>0.05).

Conclusion

Nano carbon could be used to distinguish parathyroid gland and lymph node clearly in thyroid micropapillary carcinoma surgery. It is important to protect parathyroid gland and surrounding normal tissue and is worth popularizing.

表1 67例PTMC患者不同疗法两组患者一般资料比较(例)
表2 67例PTMC患者不同疗法两组患者手术各指标比较(±s)
表3 67例PTMC患者不同疗法患者术后甲状旁激素检测结果(±s, pg/ml)
表4 67例PTMC患者不同疗法两组患者术前术后血钙水平比较结果(±s, mmol/L)
表5 67例PTMC患者不同疗法两组患者术后复发率及并发症发生率比较[例(%)]
[1]
高明,魏松锋.不断提高分化型甲状腺癌外科诊治规范化水平[J/CD].中华普外科手术学杂志(电子版),2016,10(5):361-364.
[2]
孙丹阳,郑薇,张桂芝,等. 甲状腺全切术后接受I-131治疗的微小乳头状癌淋巴结转移临床特点[J]. 中华内分泌代谢杂志,2016, 32(11):900-905.
[3]
于文斌,王天笑,张乃嵩. 双侧甲状腺乳头状癌术中甲状旁腺保护的诊治体会[J]. 中华耳鼻咽喉头颈外科杂志,2015, 50(5):406-410.
[4]
田文,姚京.分化型甲状腺癌术前分期与术式选择[J/CD].中华普外科手术学杂志(电子版),2016,10(5):365-367.
[5]
刘国松,薛会朝.三种甲状腺手术方法对甲状腺、甲状旁腺功能的影响分析[J/CD].中华普外科手术学杂志(电子版),2017,11(1):66-69.
[6]
中国抗癌协会甲状腺癌专业委员会.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床,2016,43(10):405-411.
[7]
彭冬梅,晏晨,苏安平,等. cN0甲状腺微小乳头状癌右侧喉返神经浅面及深面淋巴结转移危险因素分析[J]. 中国实用外科杂志,2016, 36(5):547-551.
[8]
任明,高国宇,郭嵩. 纳米碳对甲状腺癌手术中甲状旁腺的保护作用[J]. 中国普通外科杂志,2017, 26(11):1489-1493.
[9]
Ieni A, Barresi V, Cardia R,et al.The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution[J]. Reviews in Endocrine and Metabolic Disorders,2017,17(4):521-527.
[10]
Higuchi M, Hirokawa M, Suzuki A,et al. Cytological features of solid variants of papillary thyroid carcinoma: a fine needle aspiration cytology study of 18 cases[J]. Cytopathology,2017,28(4):268-272.
[11]
Lilo MT, Bishop JA, Ali SZ. Hobnail variant of papillary thyroid carcinoma: A case with an unusual presentation[J]. Diagnostic Cytopathology,2017,45(8):754-756.
[12]
李德伟,王强,李宁,等. 纳米碳在甲状腺微小乳头状癌手术中的应用研究[J]. 中华内分泌外科杂志,2016, 10(4):298-302.
[13]
Jovanovic MD, Zivaljevic VR, Diklic AD,et al. Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases[J]. European Archives of Oto-Rhino-Laryngology,2017,274(2):997-1004.
[14]
吴干勋,蔡丽,胡俊兰,等. 纳米碳在甲状腺癌行甲状腺全切加双侧中央区清扫中的作用[J]. 中华医学杂志,2015, 95(12):912-916.
[1] 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315.
[2] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[3] 黄崇植, 肖映胜, 杨熙鸿, 林炘. 甲状腺下动脉的上行分支在甲状腺术中定位喉返神经的应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 607-610.
[4] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[5] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[6] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[7] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[8] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[9] 樊丽超, 郭瑾瑛, 陈鑫. 野生型RET与RET/PTC融合基因检测对甲状腺乳头状癌中央区淋巴结清扫的指导意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 631-635.
[10] 徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[11] 刘化胜, 王洪霞, 马正, 王磊. 1例复杂的A3型甲状旁腺腺瘤功能亢进的手术治疗[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 705-706.
[12] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[13] 张蓉, 秦洪真, 杨晓冬, 刘爽, 刘明锋, 曹秀堂. 分化型甲状腺癌术后康复锻炼的临床应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 439-442.
[14] 周加军, 余永武, 周涵, 刘勇, 张凌. 甲状旁腺切除对继发性甲状旁腺功能亢进患者骨密度及骨代谢的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 706-710.
[15] 周加军, 余永武, 周涵, 张凌. 358例继发性甲状旁腺功能亢进症患者异位甲状旁腺的检出及分布情况分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 381-385.
阅读次数
全文


摘要